Carmela Martini
Overview
Explore the profile of Carmela Martini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
96
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nturubika B, Guardia C, Gershlick D, Logan J, Martini C, Heatlie J, et al.
Br J Cancer
. 2024 Aug;
131(8):1263-1278.
PMID: 39217195
Background: This study focuses on the role of lysosomal trafficking in prostate cancer, given the essential role of lysosomes in cellular homoeostasis. Methods: Lysosomal motility was evaluated using confocal laser...
2.
Logan J, Martini C, Sorvina A, Johnson I, Brooks R, Caruso M, et al.
Sci Data
. 2024 Aug;
11(1):852.
PMID: 39117701
The diagnosis of prostate cancer using histopathology is reliant on the accurate interpretation of prostate tissue sections. Current standards rely on the assessment of Haematoxylin and Eosin (H&E) staining, which...
3.
Tang J, Lam G, Brooks R, Miles M, Useckaite Z, Johnson I, et al.
Cancer Lett
. 2024 Jan;
585:216639.
PMID: 38290660
The highly heterogenous nature of colorectal cancer can significantly hinder its early and accurate diagnosis, eventually contributing to high mortality rates. The adenoma-carcinoma sequence and serrated polyp-carcinoma sequence are the...
4.
Bates M, Mullen D, Lee E, Costigan D, Heron E, Kernan N, et al.
Pathol Res Pract
. 2023 Dec;
253:155020.
PMID: 38103365
Objective: New prognostic biomarkers, and bio-signatures, are urgently needed to facilitate a precision medicine-based approach to more effectively treat patients with high-grade serous ovarian cancer (HGSC). In this study, we...
5.
Martini C, Logan J, Sorvina A, Prabhakaran S, Ung B, Johnson I, et al.
Virchows Arch
. 2023 Sep;
PMID: 37773453
No abstract available.
6.
Lam G, Martini C, Brooks T, Prabhakaran S, Hopkins A, Ung B, et al.
Cancers (Basel)
. 2023 Sep;
15(18).
PMID: 37760601
Background: Early diagnosis is the key to improving outcomes for patients with melanoma, and this requires a standardized histological assessment approach. The objective of this survey was to understand the...
7.
Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer
Martini C, Logan J, Sorvina A, Prabhakaran S, Ung B, Johnson I, et al.
Virchows Arch
. 2023 Sep;
485(4):723-728.
PMID: 37704825
High-grade prostatic intraepithelial neoplasia (HGPIN) is a well-characterised precursor lesion in prostate cancer. The term atypical intraductal proliferations (AIP) describes lesions with features that are far too atypical to be...
8.
Lazniewska J, Li K, Johnson I, Sorvina A, Logan J, Martini C, et al.
Sci Rep
. 2023 Aug;
13(1):13489.
PMID: 37596305
Prostate cancer (PCa) development and progression relies on the programming of glucose and lipid metabolism, and this involves alterations in androgen receptor expression and signalling. Defining the molecular mechanism that...
9.
Lam G, Sorvina A, Martini C, Prabhakaran S, Ung B, Lazniewska J, et al.
Neoplasia
. 2023 Aug;
43:100924.
PMID: 37562257
Cutaneous melanoma is the deadliest form of skin neoplasm and its high mortality rates could be averted by early accurate detection. While the detection of melanoma is currently reliant upon...
10.
Sorvina A, Martini C, Prabhakaran S, Logan J, Ung B, Moore C, et al.
Pathology
. 2023 Jul;
55(6):792-799.
PMID: 37422404
The presence of intraductal carcinoma of the prostate (IDCP) correlates with late-stage disease and poor outcomes for patients with prostatic adenocarcinoma, but the accurate and reliable staging of disease severity...